M. Muers (Leeds, United Kingdom), C. Brambilla (Grenoble, France)
Prognostic value of the oestrogen receptor in operated NSCLC
S. Kahraman, F. Kadakal, A. Uysal, G. Aras, V. Yilmaz (Istanbul, Turkey)
|   |
Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells
C. C. Tu, W. J. Wu (Taichung, Taiwan)
| |
The response to erlotinib third-line treatment in bronchioalveolar carcinoma in the absence of EGFR expression
P. Krawczyk, W. Remiszewski, B. Gryglicka, M. Pelak, E. Czekajska-Chehab, E. Warda, K. Wojas-Krawczyk, O. Jankowska, J. Milanowski (Lublin, Poland)
| |
Impact of radiotherapy on survival rates in chemotherapy treated non small cell lung cancer patients
G. Hillas, S. Nikolakopoulou, I. Kostara, H. Dimitropoulos, K. Sagris, P. Bakakos, F. Vlastos (Athens, Greece)
| |
Impact of radiotherapy on survival rates in chemotherapy treated small cell lung cancer patients
G. Hillas, S. Nikolakopoulou, I. Kostara, K. Sagris, H. Dimitropoulos, P. Bakakos, D. Veldekis, F. Vlastos (Athens, Greece)
| |
Study of patients with lung cancer treated surgically in Albania during the period 2000-2003
R. Oketa, J. Bushati, M. Nanushi (Tirana, Albania)
| |
Epidemiological and clinical predictors of survival during the first year of the treatment in non-small cell lung cancer patients
T. Sarcev, J. Stanic, A. Andjelkovic, B. Zaric (Sremska Kamenica, Republic Of Serbia)
| |
Chemotherapy induced neutropenia in lung cancer patients: a single centre study
H. Peek, M. van der Vegt, J. Janssen, Y. Berk (Nijmegen, Netherlands)
| |
Survival of elderly patients with non-small lung cancer tretaed with combined chemotherapy and radiotherapy
D. Sazdanic-Velikic, N. Secen, D. Bursac, A. Tepavac, G. Popovic, B. Perin, M. Antonic (Sremska Kamenica, Republic Of Serbia)
| |
Erlotinib as salvage treatment after failure to gefitinib in non-small cell lung cancer
M. Wong, A. Lo, J. Lam, B. Lam, J. Wang, D. Lam, M. Ip, J. Ho (Hong Kong, Hong Kong; Macao, Macao)
| |
A preliminary study on targeted therapies in advanced lung cancer patients
E. Boutsikou, P. Zarogoulidis, E. Galaktidou, I. Sapardanis, G. Balassoulis, L. Sakkas, T. Kontakiotis, K. Zarogoulidis (Exohi, Thessaloniki, Thessaloniki, Greece)
| |
Effectiveness of photodynamic therapy (PDT) in lung cancer treatment
S. V. Orlov, V. A. Gerasin, A. B. Butenko, A. V. Derevyanko, L. V. Stelmach, M. A. Urtenova (Saint-Petersburg, Russian Federation)
| |
Results of surgical management of pulmonary adenocarcinoma in 1a stage (T1N0M0): lessons learned
V. Parshin, S. Grigorieva, H. Mirzoyan, D. Bazarov (Moscow, Russian Federation)
| |
Malignant pleural effusion management by tunneled pleural catheter
I. Vidal Garcia, J. Ortiz de Saracho y Bobo, E. Juarez Moreno, E. Castro Rodriguez, R. Castrodeza Sanz (Ponferrada, Spain)
| |
Adjuvant chemotherapy in stage Ib of non-small cell lung cancer (NSCLC)-experience of a pneumology department
S. Andre, M. J. Guimaraes, C. Valente, A. Pego, A. Sousa, M. Loureiro, M. Baganha (Coimbra, Portugal)
| |
Tobacco exposure and survival in non small cell lung cancer patients treated with erlotinib
J. Gomes, A. Antunes, C. Lima, A. Barroso, D. Ferreira, S. Neves, S. Conde, B. Parente (Vila Nova de Gaia, Portugal)
| |
Lung function and quality of life after surgical treatment of non-small cell lung cancer – preliminary results
B. Wajda, K. Kuziemski, K. Specjalski, K. Lewandowska, L. Górska, W. Rzyman, E. Jassem (Gdansk, Poland)
| |
Does expression of betatubulin 3 correlate between primary non small cells lung cancer tumor and metastases?
J. B. Roseau, A. M. Taseï, V. Pradel, D. Figarella-Branger, P. Astoul (Toulon, Marseille, France)
| |
Survival prognosis and target therapy best response in adenocarcinoma lung cancer pts with mutation EGFR gene
L. Stelmakh, S. Orlov, I. Dvorakovskaya (St-Petersburg, Russian Federation)
| |
Bcl-2 as a prognostic factor for survival in small-cell lung cancer
B. Ilievska Poposka, S. Atanasova, T. Stefanovski, S. Smickova, G. Petrusevska (Skopje, Fyrom)
| |